1. Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. (25th March 2022) Authors: Zhang, Jing-Hao; Zhang, Xin; Zhou, Zhen-Hua; Zhu, Xiao-Jun; Zheng, Chao; Li, Man; Jin, Shu-Gen; Mao, De-Wen; Xue, Jing-Dong; Shi, Wei-Bing; Chi, Xiao-Ling; Wang, Xian-Bo; Li, Xiao-Dong; Li, Yong; Wang, Hui; Li, Qin; Zhou, Da-Qiao; Wang, Cheng-Bao; Shi, Chang-He; Li, Cheng-Zhong Other Names: Kung Woon-Man Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bushenjianpi formula combined with entecavir for HBeAg-negative chronic hepatitis B patients: a multicentre, randomised, double-blind, placebo-controlled trial. (October 2016) Authors: Gao, Yue-Qiu; Zhang, Xin; Li, Man; Zhou, Zhen-Hua; Sun, Xue-Hua; Zhu, Xiao-Jun; Jin, Shu-Gen Journal: Lancet Issue: Volume 388(2016)Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗